SMTL ID : 4rvj.1 (1 other biounit)

Crystal structure of multidrug-resistant clinical isolate A02 HIV-1 protease in complex with amprenavir

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

homo-dimer

Ligands

1 x 478: {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER(Non-covalent)

478.1: 24 residues within 4Å: Chain A: L.23, D.25, G.27, A.28, D.30, V.32, I.47, G.48, G.49, I.50, P.81, T.82, I.84 Chain B: L.23, D.25, G.27, A.28, D.29, D.30, V.32, G.48, G.49, I.50, I.84 23 PLIP interactions: 13 interactions with chain A, 10 interactions with chain B Hydrophobic interactions: A:L.23, A:A.28, A:V.32, A:I.47, A:I.50, A:P.81, A:T.82, A:I.84, B:L.23, B:A.28, B:I.84 Hydrogen bonds: A:D.29, A:D.30, A:D.30, B:G.27, B:G.27, B:G.27, B:D.29, B:D.30 Water bridges: A:I.50, B:I.50 Salt bridges: A:D.25, B:D.25

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yedidi, R.S. et al., Enhanced antiviral activity by the P2-tris-tetrahydrofuran moiety of GRL-0519, a novel nonpeptidic HIV-1 protease inhibitor (PI), against multi-PI-resistant and highly darunavir-resistant strains of HIV-1. To be Published

Release Date

2016-05-04

Peptides

HIV-1 protease: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

HIV-1 protease

Related Entries With Identical Sequence